• Bloomberg.com
Batches of seed virus are being developed for potential vaccine production, according to WHO. Paris-based Sanofi-Aventis SA, Baxter International Inc. of Deerfield, Illinois, and GlaxoSmithKline Plc of London are talking with world health authorities
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: